ENTYVIO subst sèche 300 mg flac
7680632850018
CH-63285
L04AG05
07.15.0.
Reimbursement limitations:
ENTYVIO
Indiqué pour le traitement de la rectocolite hémorragique active modérée à sévère et de la …
1 / 3
google
Details
- Product number
- 6328501
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: vedolizumabum 300 mg, histidinum, histidini hydrochloridum monohydricum, arginini hydrochloridum, saccharum, polysorbatum 80, pro vitro.
Articles (1)
Entyvio, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 2384.05
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2015
Authorization holder
Takeda Pharma AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 63285
- Drug name
- Entyvio, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPA
- ATC Code
- L04AG05
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 11/02/2015
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ENTYVIO subst sèche 300 mg flac
- Description (DE)
- ENTYVIO Trockensub 300 mg Durchstf
- Market launch
- 11/02/2015
- Narcotic (BTM)
- No